JP Morgan XPeng · XPEV

JPMorgan Cuts XPeng Price Target to HK$108

1 min read Reproduced verbatim
Rating
Overweight
Target
HK$108
from HK$118 (−8%)
JP Morgan and XPeng logos

What the analyst said

JPMorgan analyst Nick Lai lowered the price target on XPeng (H-Shares) (9868:HK) (NYSE: XPEV) to HK$108 (from HK$118) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Track record

Firm track recordJP Morgan: 64% of its 28 targets at least a year old were reached within 12 months (#22 of 26 firms). Accuracy ranking →

JP Morgan on XPeng

JP Morgan price targets on XPeng

5 calls from February 9, 2026 to September 30, 2026. The target went from HK$135 to HK$45 (−67%). The rating moved from Buy to Hold.

JP Morgan target
  1. September 30, 2026Downgraded to Hold, target cut from HK$94 (−52%)HoldHK$45
  2. August 26, 2026Target cut from HK$108 (−13%)BuyHK$94
  3. July 14, 2026 This noteTarget cut from HK$118 (−8%)BuyHK$108
  4. May 29, 2026Target cut from HK$135 (−13%)BuyHK$118
  5. February 9, 2026Earliest call shownBuyHK$135
Share

Other analysts on XPeng

CLSABuy Cut price target, kept rating Oct 23 Goldman SachsBuy Cut price target, kept rating Oct 23 Goldman SachsBuy Cut price target −11%, kept rating Oct 23 $16from $18 Morgan StanleyBuy Cut price target, kept rating Sep 15 UBSHold Initiated coverage Sep 9
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.